MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: VantagePoint
Metabolex
Parents
*Architects: Diabetes, Metabolic Disease, Dialysis, Renal & Kidney Companies (Pharmaceuticals, Biotechnology, Biosimilars)
*Portfolio Companies: Bay City
*Portfolio Companies: VantagePoint
Children
Biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat diabetes and related metabol
Metabolex has also built a portfolio of other potential diabetes therapeutics, which includes a product candidate in preclinical
The company’s lead compound, MBX-102, is a novel insulin sensitizer in Phase II clinical development (2006).